Results

Total Results: 2,080 records

Showing results for "drug".

281. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
     October 01, 2014 - and is known to be a street drug of abuse. … Research suggests new drug targets for depression. … Washington (DC): Drug Enforcement Administration, U.S. … Food and Drug Administration (FDA). Methscopolamine bromide. [internet]. … Food and Drug Administration (FDA) [accessed 2013 Aug 19]. [2 p].

282. Kravitz_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
     January 01, 2012 - Food and Drug Administration opened the door in 1997 by reinterpreting own rules. …  (clinical) approaches Slide 18: Policy  Approaches • Improve the quality of the prescription drug … Slide 19: What Is  Being  Done • Drug facts  box o Presents evidence about the benefits and

283. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - syringes of the drug at no cost. … MS drug under investigation after 11 deaths. In: Drug Discovery & Development [internet]. … Specialty pharmacy program drug list. … MAP Pharmaceuticals resubmits New Drug Application to FDA for Levadex orally inhaled migraine drug … Food and Drug Administration (FDA).

284. pneumonia-antibiotic-treatment-protocol-130718 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
     July 19, 2013 - dosing of antibiotics has been associated with poorer clinical outcomes and increased incidences of drug … PK is the study of the time course of drug absorption, distribution, metabolism, and excretion. … Antibiotics for which PK/PD measures could be used Drug Class Drug Group Drug* Aminoglycosides … Optimizing drug exposure to minimize selection of antibiotic resistance. … Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

285. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0255_06-25-2010.pdf
     January 01, 2010 - interventions (e.g., atherectomy, brachytherapy) 2) Patients undergoing PCI, with either bare metal or drug-eluting … intravascular techniques with a literature sample that mirrors contemporary treatment practices (e.g., drug-eluting … patients with coronary artery disease and patients undergoing a PCI with either a bare metal stent or a drug-eluting

286. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis – An Update to the 2006 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoarthritis-pain/research-protocol
     August 05, 2010 - evidence that standard dosing as labeled or alternative dosage strategies, such as intermittent dosing and drug … Drug (any trade name) Labeled indications Dosing Dose adjustments for special populations Oral … will also include studies that report safety in patients with rheumatoid arthritis or were taking the drug … We will use relatively broad searches, combining terms for drug names with terms for relevant research … sources may include reference lists of review articles and unpublished materials from the US Food and Drug

287. Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers (Eisenberg Center Conference Series 2006) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/eccs-2006
     September 30, 2006 - Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers (Eisenberg Center Conference Series 2006) Timeline September 30, 2006 Topic Initiated September 30, 2006 White Paper Communicating Harms and Benefits of Prescription Drugs to Hea…

288. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Experts deemed three topics as having high-impact potential: An oral drug for treating patients with … Because it has been approved for treating plaque psoriasis, cost of the drug is available. … High cost could be prohibitive and limit patient access to drug if third-party payers do not cover … The drug was administered in three loading doses as an IV infusion, 10 mg/kg, at baseline, 2 weeks, … Food and Drug Administration (FDA) approved secukinumab for treating adults with moderate-to-severe

289. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
     August 13, 2012 - submits an application to the FDA for an “investigational new drug.” … in routine clinical care after the drug is approved for marketing (phase 4). … Intervention What is the intervention of interest (e.g., a drug, device, procedure, or test)? … Coverage Which bisphosphonate drugs should be included on a drug formulary? … Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:6-12. 12. Normand SL, McNeil BJ.

290. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization
     April 05, 2012 - Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 Timeline April 04, 2012 Topic Initiated April 05, 2012 Research Report Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with…

291. Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps
     January 01, 2005 - Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs Timeline January 01, 2005 Topic Initiated January 01, 2005 Research Report Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: C…

292. AHRQ EPC Program Research Gaps Summary: Women's Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gaps-womens-health-22.pdf
     April 01, 2022 - .................................................................................... 10 Long-Term Drug … Therapies and Drug Holidays for Osteoporosis Fracture Prevention ................................... … https://effectivehealthcare.ahrq.gov/products/infertility/research 11 Long-Term Drug Therapies … • This report was used to inform a NIH Pathways to Prevention workshop, Appropriate Use of Drug … Key Findings • Evidence on the effects of long-term osteoporosis drug treatment and drug continuation

293. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
     June 01, 2010 - a class switch to a different drug in the same class. … Food and Drug Administration and the Center for Medicare and Medicaid Services. … Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making. … Drug Effectiveness Review Project. … Drug class review on the triptans: Drug Effectiveness Review Project.

294. The Effectiveness and Risks of Long-term Opioid Treatment of Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-pain-opioid-treatment/research-protocol
     December 19, 2013 - harms (e.g., depression) Exclude: Intermediate outcomes (e.g., pharmacokinetics/pharmacodynamics, drug-drug … The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency … Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief. 2011;81:1-8. … Opioid dose and drug-related mortality in patients with nonmalignant pain. … Food and Drug Administration.

295. The Effectiveness of Disease-Modifying Antirheumatic Drugs (DMARDS) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol
     March 09, 2010 - Furthermore, there are a large number of DMARDs that cannot simply be grouped by drug class. … Failure with a drug in one particular class does not necessarily predict failure with another drug in … been available for much longer then the other DMARDs, so there is greater clinical experience with the drug … and the drug is relatively inexpensive. … corticosteroids and NSAIDs FDA approval status for JIA, and examples of significant warnings from the drug

296. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - Food and Drug Administration. … Food and Drug Administration. … Food and Drug Administration. … Food and Drug Administration. … Food and Drug Administration.

297. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-p
     August 04, 2010 - Potential for 1) misinterpretation or misclassification of drug metabolizer status, along with the possibility … that it might result in excessive or inadequate dosing, and 2) selection of alternate drug that proves … Appropriateness for EHC Program Does your question include a health care drug, intervention, device

298. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Personalized drug therapy has traditionally lagged behind behavioral therapy in this regard because … Biopharm Drug Dispos. 2003 Jan;24(1):37-43. Also available: http://dx.doi.org/10.1002/bdd.336. … Drug Enforcement Administration. … Research suggests new drug targets for depression. … Washington (DC): Drug Enforcement Administration, U.S.

299. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
     October 01, 2013 - Food and Drug Administration, Silver Spring, MD Jodi B. … Food and Drug Administration (FDA) has authority over the NDC codes. … and are responsible for processing and paying prescription drug claims. … Pharmacoepidemiol Drug Saf. 2001 August;10(5):389-92. 20. … Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1199-209. 51.

300. Treatments for Seasonal Allergic Rhinitis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/allergy-seasonal/research
     July 16, 2013 - Food and Drug Administration (FDA).